Home | Wikikidney | Dialysis Units | CKD | Physicians | RNS & Administrators | Nutrition | KidneyDisasters | KIDNEYDISEASE | Patient Education | Find Unit by Address | Issues | MDRD GFR | AAKP | K DOQI | Epocrates | UpToDate | HDCN | Bills | Translate

TEXT SEARCH STRUCTURED SEARCHES PubMed MeSH Nucleotide Journals PMC Books OMIN PopSet Taxonomy DNA Sequences Protein Sequences 3D Structures Complete Genomes Books CancerChromosomes Conserved Domains 3D Domains Gene GENSAT GEO Profiles GEO DataSets HomoloGene NCBI Web Site NLM Catalog OMIM PubChem BioAssay PubChem Compound PubChem Substance SNP UniGene UniSTS for: All Subjects Free Text obesity hypertension dialysis diabetes kidney kidney disease glomerulonephritis kidney failure vascular calcification All Journals N England J Med Clin Nephrol Curr Opin Nephrol Hypertens J Am Soc Nephrol Clin J Am Soc Nephrol Proc Eur Dial Transplant Assoc Semin Nephrol Kidney Int Kidney Int Suppl Am J Kidney Dis Nephrol Dial Transplant Other Citematch Search by Citation - Hubmed works with EndNote and newsreaders CR IDMS mg/dL μmol/L AGE yrs W B F M MDRD GFR: ??? mL/min/1.73 m2

web site Epocrates | TouchCalc Clin Queries | AdvScholar | Scholar | PUBGET

epigfr.com CYSTATIN C PEDIATRIC CYSTATIN C (BETA)

Board Reviews in Chronic Kidney Disease

A patient has had an MDRD GFR of 45 cc/min for five months. What is the stage?

Stage III includes GFR levels between 30 and 59 cc/min/min². Here, the GFR is moderately decreased. At this stage one could expect to find early bone disease and anemia. The MDRD GFR can be calculated using the age, race and gender. For more information refer to the NKF KDOQI Guidelines at http://www.kdoqi.org